Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemiamarketing2021-02-26T19:09:41+00:00July 14th, 2020|2020 Press Releases, Press Releases| 更多详细信息
Invivoscribe宣布FDA批准的LeukoStrat CDx FLT3突变试剂盒作为IVD试剂盒在美国销售marketing2022-01-03T02:51:13+00:00May 19th, 2020|2020 Press Releases, Press Releases| 更多详细信息
Invivoscribe在中国向NMPA提交LeukoStrat®CDx FLT3突变检测，并扩大公司规模，在上海增加实验室，为合作伙伴提供全面支持。marketing2022-01-03T02:51:34+00:00May 12th, 2020|2020 Press Releases, Press Releases| 更多详细信息
